Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
SD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al. Keywords:
cardiorenal outcomes; empagliflozin